COVID-19 Vaccine Leaders Turn Attention to Kids, But Results Not Expected Until 2022

Pfizer, Moderna, AstraZeneca, and Johnson & Johnson all have trials of their respective vaccines underway in various age-groups. On Friday, Pfizer confirmed that it had fully enrolled its clinical trial of 2,259 participants in children 12-15, while Moderna began a clinical trial in kids 12 and above in mid-December.

However, Moderna chief executive officer, Stephane Bancel shared during the JP Morgan conference that data on those 11 and under would likely not be available until next year.